The trial was funded by the drug's maker, Merck, and involved 253 American and British participants. All had suffered from an unexplained or untreatable cough that had lasted for an average of almost 15 years.
https://ift.tt/2VB3UEb
from WebMD Health https://ift.tt/3camEA7
by
Comments
Post a Comment